Japan Hospice Holdings Past Earnings Performance
Past criteria checks 1/6
Japan Hospice Holdings has been growing earnings at an average annual rate of 32.2%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 22% per year. Japan Hospice Holdings's return on equity is 18.3%, and it has net margins of 5.1%.
Key information
32.2%
Earnings growth rate
30.5%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 22.0% |
| Return on equity | 18.3% |
| Net Margin | 5.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Japan Hospice Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 10,903 | 551 | 384 | 0 |
| 31 Mar 24 | 10,351 | 669 | 350 | 0 |
| 31 Dec 23 | 9,871 | 681 | 344 | 0 |
| 30 Sep 23 | 9,482 | 752 | 340 | 0 |
| 30 Jun 23 | 9,034 | 669 | 341 | 0 |
| 31 Mar 23 | 8,520 | 547 | 390 | 0 |
| 31 Dec 22 | 7,894 | 454 | 384 | 0 |
| 30 Sep 22 | 7,251 | 336 | 372 | 0 |
| 30 Jun 22 | 6,708 | 314 | 358 | 0 |
| 31 Mar 22 | 6,267 | 268 | 334 | 0 |
| 31 Dec 21 | 6,019 | 240 | 343 | 0 |
| 30 Sep 21 | 5,729 | 210 | 324 | 0 |
| 30 Jun 21 | 5,450 | 167 | 334 | 0 |
| 31 Mar 21 | 5,183 | 146 | 336 | 0 |
| 31 Dec 20 | 4,916 | 107 | 332 | 0 |
| 30 Sep 20 | 4,729 | 162 | 359 | 0 |
| 30 Jun 20 | 4,532 | 198 | 357 | 0 |
| 31 Mar 20 | 4,351 | 255 | 347 | 0 |
| 31 Dec 19 | 4,193 | 297 | 342 | 0 |
| 30 Sep 19 | 3,948 | 234 | 335 | 0 |
| 31 Dec 18 | 3,015 | 149 | 285 | 0 |
| 31 Dec 17 | 1,895 | -60 | 209 | 0 |
Quality Earnings: 7061 has a high level of non-cash earnings.
Growing Profit Margin: 7061's current net profit margins (5.1%) are lower than last year (7.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7061's earnings have grown significantly by 32.2% per year over the past 5 years.
Accelerating Growth: 7061's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 7061 had negative earnings growth (-17.6%) over the past year, making it difficult to compare to the Healthcare industry average (8.2%).
Return on Equity
High ROE: 7061's Return on Equity (18.3%) is considered low.